Applications of 4-Deoxypyridoxine Hydrochloride in Industrial Manufacturing

4-Deoxypyridoxine Hydrochloride serves as a vital intermediate and functional additive in selected high-value chemical and pharmaceutical sectors. We supply the material to manufacturers requiring consistent quality for precise formulations, complex synthesis, and stringent regulatory compliance. Below are core downstream application scenarios, each with specific technical demands and regulatory requirements.

1. Active Pharmaceutical Ingredient (API) Synthesis for Antitubercular Agents

Our 4-Deoxypyridoxine Hydrochloride is widely used as a building block in the synthesis of antitubercular drug intermediates. Pharmaceutical manufacturers utilize this compound in multi-step organic syntheses to construct analogs and derivatives designed for the inhibition of mycobacterial vitamin B6 pathways. It supports the development of novel candidates requiring high-purity input, strictly monitored process controls, and precise impurity profiling per international health authority requirements.

Industry compliance standards

• Current Good Manufacturing Practice (cGMP, FDA 21 CFR Part 210/211)
• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP General Chapters <1121>, <1092>
• European Pharmacopoeia (Ph. Eur.) applicable analytical procedures

Typical usage ratio

• Applied at 0.1%–2.5% molar ratio in targeted step reactions as a precursor or blocking agent, adjusted based on route optimization and process yield studies.

Downstream process integration

• Charged directly to reaction vessels during heterocycle formation or as a reactant in selective deoxygenation steps within the synthesis route for pyridoxine-based antitubercular analogs.

Final product types

• Intermediate compounds for first- and second-line antitubercular drugs
• Small molecule leads for drug discovery programs
• Reference standards for analytical method validation
• Pilot batches for clinical research material supply

2. Nutritional Antagonist Studies in Food Science Research

The compound finds specialized use in food and nutritional research facilities investigating vitamin B6 metabolism inhibition and associated physiological pathways. Research-grade 4-Deoxypyridoxine Hydrochloride is formulated into controlled dietary matrices and model feeds for animal or cell culture studies, requiring batch traceability, absence of cross-contaminants, and adherence to food research safety guidelines. Researchers demand defined purity for reproducibility and accurate measurement of toxicological endpoints or metabolic disturbances.

Industry compliance standards

• ISO/IEC 17025-certified laboratory materials
• OECD Principles of Good Laboratory Practice (GLP)
• US National Institutes of Health (NIH) Animal Study Provisions
• European Food Safety Authority (EFSA) feed additive safety guidelines

Typical usage ratio

• Mix at 0.01%–0.09% w/w in test diets, titrated according to body weight or cell density; adjusted in research protocols based on experiment design and tolerability thresholds outlined in literature.

Downstream process integration

• Blended into experimental feedstocks, animal diets, or cell culture supplements during pre-formulation; dosed by mass balance for precise intake tracking throughout trial periods.

Final product types

• Vitamin B6 antagonist assay kits
• Specialty animal model feed premixes
• Custom research reference materials
• Controlled-nutrient laboratory diets for academic and CRO studies

3. Diagnostic Reagents in Clinical and Biomedical Analysis

Clinical diagnostic companies use this compound in reagent formulations for the quantification and functional analysis of vitamin B6-dependent enzymes. Ready-to-use test kits for research and clinical laboratory settings incorporate the material with exacting standardization, requiring full traceability, contaminant control, and compatible formulation for biosample testing environments as per in vitro diagnostic (IVD) regulatory regimes. Stability and batch homogeneity are critical to avoid cross-reactivity in sensitive clinical panels.

Industry compliance standards

• IVD Medical Device Directive (98/79/EC), transitioning to EU IVDR (2017/746)
• ISO 13485-certified QMS for diagnostics
• US FDA 21 CFR Part 820 for medical devices
• CLSI guidelines for quality assurance in laboratory-developed tests

Typical usage ratio

• Included at 0.02–0.08 mg/mL in liquid test reagent preparations or at similar concentrations in lyophilized formats, optimized for signal response in target enzyme assays.

Downstream process integration

• Added to master reagent mixes during final blending and sterile filtration before aliquoting, ensuring integrity for shelf life and repeatability in diagnostic test kits.

Final product types

• Vitamin B6 metabolism assay kits
• Quality control calibrators for hospital labs
• Enzymatic detection reagent sets
• Point-of-care diagnostic panels

4. Research-Grade Chemical Synthesis of Pyridine Derivatives

Chemical manufacturers employ this compound as a key intermediate in the preparation of diverse pyridine derivatives for applications in medicinal chemistry and crop protection R&D. This application demands flexible batch sizes, detailed impurity profiles, and robust documentation to support process development and reproducibility for industrial research and scale-up studies. Customers require supply consistency for rapid synthesis iteration, often integrating our material in combinatorial or parallel synthetic approaches.

Industry compliance standards

• ISO 9001-certified manufacturing
• REACH Regulation (EC) No 1907/2006 (for registered downstream use)
• Responsible Care process safety protocols
• Chemical Manufacturer’s Association best practice guidelines

Typical usage ratio

• Typically introduced at 1–10 mol% as a functional core or transformation target, tailored according to route specificity, target molecule, and yield optimization criteria.

Downstream process integration

• Mixed directly in batch or flow reactors during nucleophilic substitution, reduction, or as a Grignard coupling partner to elaborate structurally related pyridine compounds.

Final product types

• Pyridine-based reference analogs
• Synthetic precursors for agrochemical R&D
• Protected intermediates for fine chemical processes
• Medicinal chemistry screening samples

5. Toxicological Reference Material in Environmental Safety Testing

Environmental laboratories and regulatory authorities incorporate this material in controlled studies evaluating the risk and environmental impact of vitamin B6 antagonists on aquatic or terrestrial organisms. Supply must support validated toxicological reference protocols to meet regulatory and ISO requirements, with comprehensive documentation for chain of custody and purity. Data from these tests inform regulatory decisions on chemical management and registration.

Industry compliance standards

• ISO 17034: General requirements for the competence of reference material producers
• OECD Test Guidelines for Chemicals (e.g., TG 203, 202, 201)
• USEPA Good Laboratory Practice (GLP) Standards
• EN ISO/IEC 17025 for analytical quality

Typical usage ratio

• Prepared in test media at concentrations from 0.1–10 mg/L, with adjustments according to organism sensitivity, method endpoints, and environmental relevance, as specified in each study protocol.

Downstream process integration

• Dissolved into test aquaria or exposure chambers at precisely metered dose rates; calibrators prepared for reference curve establishment and dose-response validation.

Final product types

• Certified toxicology reference solutions
• Test mixtures for OECD or EPA environmental risk assessments
• Standardized positive controls in ecotoxicology
• Validation samples for environmental safety monitoring